Atara Biotherapeutics Inc. buy BiotechBee
Start price
01.10.23
/
50%
€1.41
Target price
31.01.26
€3.00
Performance (%)
-74.00%
Price
18.06.24
€0.37
Summary
This prediction is currently active. Massive losses of -74.00% have been the result for the BUY prediction by BiotechBee. This prediction currently runs until 31.01.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Atara Biotherapeutics Inc. | - | - |
iShares Core DAX® | -3.033% | -0.013% |
iShares Nasdaq 100 | -3.554% | -2.546% |
iShares Nikkei 225® | -3.938% | 2.183% |
iShares S&P 500 | -1.517% | -0.882% |
According to BiotechBee what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Atara Biotherapeutics Inc. diskutieren
Buy mit Kursziel 3,0